Abstract:A dual-response (near-infrared, alternating magnetic field) multifunctional nanoplatform was developed based on urokinase plasminogen activators (uPA)-loaded metal–organic-framework (MOF)-derived carbon nanomaterials (referred to below) for thrombolytic therapy. uPA loaded in mesoporous CFs could be released under the action of near-infrared (NIR)-mediated photothermy to achieve superficial thrombolysis. More importantly, with the assistance of alternating magnetic field (AMF), this system could also precisely heat the thrombosis in the deep tissue area. Quantitative experiments proved that the thrombolytic efficiency of this dual-response system at deep venous thrombosis was nearly 6 times than that of NIR alone. This is the first application that MOF-derived carbon nanomaterials in the field of targeted thrombolysis. To our delight, the MOF-derived carbon nanomaterials (CFs) not only maintained the drug-carrying capacity, but also endowed CFs with reliable magnetic targeting ability. More encouragingly, the CFs also showed extraordinary angiogenic performance, thus opening up the prospect of its clinical application.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c03134?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c03134</a>.Particle size distribution of CFs (Figure S1a). Stability of the CFs hydrodynamic size during different incubation periods with serum (Figure S1b). High-resolution XPS spectra of (a) Fe 2p, (b) O 1s, and (c) C 1s (Figure S2). The summary of nitrogen adsorption–desorption analysis of MOFs (Fe) and CFs samples (Table S1). Pore size distribution of (a) MOFs (Fe) and (b) CFs samples (Figure S3). VSM curve of at room temperature (Figure S4). The photothermal effect and magnetothermal effect of CFs (Figure S5). uPA release from after being placed in saline over 7 days (Figure S6). The thickness of pork (Figure S7a). Deep evaluation of the magnetic field attracting CFs using different thickness of pork (scale bar = 1 cm) (Figure S7b). SEM analysis of thrombolysis (scale bar = 2 μm) (Figure S8). Scanning electron microscopy (SEM) images and the elemental mapping data of the degradation of CFs at the thrombus site at (a) 20 min, (b) 40 min, and (c) 1 h (scale bar = 5 μm) (Figure S9). SEM images of RBCs treated with different concentrations of CFs (scale bar = 5 μm) (Figure S10). Cell viability of HSF and HUVECs treated with different concentrations of CFs for 24 h (Figure S11a). Cell viability with various concentrations of CFs, CFs + NIR, CFs + AMF for 12 and 48 h (Figure S11b). Cell viability of HUVECs cocultured with different concentrations of CFs and VEGF for various time as indicated above. (Error bars represent the standard deviation of six separate measurements) (Figure S12). Photos (clots are marked in blue circles, scale bar = 1 cm) of clots before and after treatment for 24 h (Figure S13). The amount of Fe in the major organs and blood after treatment for 7 days (Figure S14). Four indicators of coagulation in SD rats (Figure S15a). Some indexes of liver and kidney function in SD rats (Figure S15b). The average body weight of rats in each group during the treatment periods (Figure S16) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c03134/suppl_file/am1c03134_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Disassembling blood clots and recovering blood oxygen function with strong magnetic field for severe COVID-19 patients

Interventional Removal of Travelling Microthrombi Using Targeted Magnetic Microbubble

Mechanisms of COVID-19 thrombosis in an inflammatory environment and new anticoagulant targets

Magneto-sonothrombolysis with combination of magnetic microbubbles and nanodroplets

Electrophysiological Modeling Study of ECG T-wave Alternation Caused by Ultrahigh Static Magnetic Fields

Magnetic Nanoparticles Mediated Thrombolysis–A Review

[Traditional Chinese medicine theoretical mechanism of blood-activating and stasis-resolving therapy combined with thrombolysis/thrombectomy in improving clinical efficacy]

[Efficacy of Low-Frequency Magnetic Therapy in Patients with COVID-19 Pneumonia]

Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID‐19 patients

Magnetically Powered Microrobotic Swarm for Integrated Mechanical/Photothermal/Photodynamic Thrombolysis

Chemical Conjugation of Urokinase to Magnetic Nanoparticles for Targeted Thrombolysis

The cross-talk of lung and heart complications in COVID-19: Endothelial cells dysfunction, thrombosis, and treatment

Pathophysiological mechanisms of thrombosis in acute and long COVID-19

Targeted Thrombolytic Therapy with Metal–Organic-Framework-Derived Carbon Based Platforms with Multimodal Capabilities

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Concurrent Cerebral, Splenic, and Renal Infarction in a Patient With COVID-19 Infection

Advances in smart delivery of magnetic field-targeted drugs in cardiovascular diseases

Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients

Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines

Blood clot detection using magnetic nanoparticles

Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19